UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 10, 2016
TESARO, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(state or other jurisdiction of incorporation) | | 001-35587
(Commission
File Number) | | 27-2249687
(I.R.S. Employer
Identification No.) |
1000 Winter Street
Suite 3300
Waltham, Massachusetts | | 02451 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (339) 970-0900
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 7 — Regulation FD
Item 7.01 Regulation FD Disclosure.
Lonnie Moulder, Chief Executive Officer of TESARO, Inc. (“TESARO”), and Mary Lynne Hedley, President and Chief Operating Officer of TESARO, will present at the Leerink Partners 5th Annual Global Healthcare Conference on February 10, 2016 at 2:40 p.m. Eastern time. A live webcast of the presentation will be accessible via the Investors page of the TESARO website at www.tesarobio.com. Furnished as Exhibit 99.1 to this Current Report are slides being used by TESARO for the presentation.
Section 9 — Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No. | | Description |
| | |
99.1 | | TESARO, Inc. investor presentation for the Leerink Partners 5th Annual Global Healthcare Conference, dated February 10, 2016. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TESARO, Inc. |
| |
| |
| By: | /s/ Joseph L. Farmer |
| | Joseph L. Farmer |
| | Senior Vice President, General Counsel and Secretary |
Dated: February 10, 2016
3
